Regular vs Intermittent Dose Ibuprofen for the Treatment of Ankle Sprains in Children
2 other identifiers
interventional
100
1 country
1
Brief Summary
Ankle sprains are common in children, and optimal pain management has not been determined. We hypothesize that children age 7-17 years of age with acute ankle sprain randomized to receive regular dose ibuprofen will show a greater improvement in degree of pain,disability,swelling and tenderness four days following injury as compared to children who take ibuprofen only intermittently for pain relief during the same time period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 23, 2010
CompletedFirst Posted
Study publicly available on registry
March 25, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedResults Posted
Study results publicly available
November 26, 2019
CompletedNovember 26, 2019
November 1, 2019
6.3 years
March 23, 2010
August 22, 2017
November 7, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Visual Analog Scale (VAS) Pain on Weight Bearing From Baseline
Change in Pain Scale 0-10 Visual Analog Scale with 0 being no pain and 10 being unbearable pain. Outcome is measured in mm as measured from 0 to where the participant places indicated their pain to be on the scale.
4 days
Change in Visual Analog Scale (VAS) for Disability
0-10 Visual Analog Scale with 0 being no disability and 10 being severe disability. Patients are asked to place a line on the VAS to where they believe their disability to be. The final outcome is then measured in mm from 0 to the line placed by the patient.
4 days
Study Arms (2)
Regular Ibuprofen Dosing
ACTIVE COMPARATORRegular Ibuprofen Dosing throughout 4 days of study
PRN Ibuprofen dosing
ACTIVE COMPARATORAs needed Ibuprofen dosing
Interventions
Eligibility Criteria
You may qualify if:
- Ages 7-17 years who have suffered an isolated ankle sprain within the last 24 hours
- Able to return for follow-up with research assistant in 4 days time
You may not qualify if:
- Preexisting Metabolic bone disease
- Bilateral ankle sprains
- Fractured ankle as demonstrated on X-ray
- Suspected Salter 1 fracture or syndesmosis injury
- Other traumatic injuries
- History of Gastric ulcers or renal disease
- Known or suspected allergy/sensitivity to ibuprofen
- Previous ankle sprain of affected ankle within last 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
London Health Sciences Centre
London, Ontario, N6A 5W9, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Rodrick Lim
- Organization
- LHSC Lawson HRI
Study Officials
- PRINCIPAL INVESTIGATOR
Rodrick Lim, MD,FRCPC,FAAP
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 23, 2010
First Posted
March 25, 2010
Study Start
February 1, 2010
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
November 26, 2019
Results First Posted
November 26, 2019
Record last verified: 2019-11